InvestorsHub Logo
Followers 40
Posts 3318
Boards Moderated 0
Alias Born 08/18/2009

Re: Paullee post# 414

Tuesday, 10/15/2019 9:21:51 AM

Tuesday, October 15, 2019 9:21:51 AM

Post# of 1141
I am quite sure that's incorrect. They have licensed their C1 tech to Dupont exclusively for all applications except "human and animal health" which implies bio/pharma space though there is surely some grey area. And even for the pharma space, they share the license with Dupont (meaning Dupont can also develop it for pharma). At least that's my understanding. And of course they can still out-license it again / sell it outright if they choose.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DYAI News